• Sonuç bulunamadı

55. Durupınar B. Antibiyotiklere dirençte yeni eğilimler. Klimik Dergisi 2001;14(2):47- 56.

56. Dündar V, Akata F, Uzun C, Otkun M, Karapıar F, Tuğrul M. Trakya Üniversitesi Eğitim Uygulama ve AraĢtırma Hastanesi‟nde burun taĢıyıcılarından izole edilen Staphylococcus aereus suĢlarında oksasilin direnci. Klinik Derg 1994; 7:159-62.

57. Dündar V. Metisiline Dirençli Stafilokok Ġnfeksiyonları. Klimik Dergisi 2000; 13:26-27

58. Dündar V, Öztürk DD. Stafilokok infeksiyonları. Ġnfeksiyon Hastalıkları ve Mikrobiyolojisi. In: Willke Topçu A, Söyletir G, Doganay M. (editörler) Nobel Tıp Kitabevi, Ankara, 2002, s. 1507-1516.

59. Ehlert K. Methicillin-resistance in Staphylococcus aureus melocular basis, novel targets and antibiotic therapy, Curr Pharm Des 1999, 5:45

60. Elçi SD. Metisilin dirençli Staphylococcus aureus suĢlarının antibiyotik duyarlılıkları ve pulse field jel elektroforezi ile tiplendirilmesi. Yüksek Lisans Tezi, Hacettepe Üniversitesi Fen Bilimleri Enstitüsü, 2005, Ankara.

61. Ender M, McCallum N, Adhikari R, Berger-Bachi B. Fitness cost of SCCmec and methicillin resistance levelsin Staphylococcus aureus. Antimicrob Agents Chemother 2004; 48(6): 2295-7. 62. Enright MC, Robinson DA, Randle G, Feil EJ, Grundmann H, Spratt BG. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc. Natl. Acad. Sci. USA. 2002, 99(11): 7687-92.

63. Erdem Z. Metisilin dirençli Staphylococcus aureus suĢlarının moleküler tiplendirmesi. Adnan Menderes Üniversitesi Sağlık Bilimleri Enstitüsü, Yüksek Lisans Tezi, 2011.

64. Fang FC, McClelland M, Guiney DG, Jackson MM, Hartstein AJ, Morthland VH et al. Value of molecular epidemiologic 67 analysis in a nosocomial methicillin – resistant Staphlococcus aureus outbreak. JAMA. 1993, 270: 1323–1328.

65. Forbes BA, Sahm DF, Weissfeld AS. Staphylococcus, Micrococcus and Similar Organisms (Eds) Bailey and Scott‟s Diagnostic Microbiology Mosby, St. Lois London, 2002, s. 285-292. 66. Forbes BA, Sahm DF, Weissfeld. A.S. Laboratory Methods and Strategies For Antimicrobial

Susceptibility Testing: Bailey and Scott s Diagnostic Microbiology. 12th Ed. USA: Mosby, 2007, p: 187-214.

67. Foster TJ, Höök M. Surface protein adhesins of Staphylococcus aureus. Trends Microbiology 1998; 6:484-488.

68. Francois P, Pittet D, Bento M, Pepey B, Vaudaux P, Lew D et al. Rapid Detection of Meticillin- Resistant Staphylococcus aureus Directly from Sterile or Nonsterile Clinical Samples by a New Molecular Assay. J Clin Microbiol 2003;41: 254-60.

65

69. Gao J, Stewart GC. Regulatory elements of the Staphylococcus aureus Protein A (spa) Promoter Journal Bacteriology 2004;186(12): 3738-3748.

70. Gill SR, Fouts DE, Archer GL. Insight on evolution of virulence and resistance from the complete genome analysis of an early methcillin-resistant Staphylococcus aureus strainanf biofilm- producing methicillin-resistant Staphylococcus epidermidis strain. Journal of Bacteriololgy, 2005;87: 2426-2438.

71. Gillet Y, Issartel B, Vanhems P, Fournet JC, Lina G, Bes M, et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients.Lancet 2002; 359(9308): 753-9. 72. Goering RV, Dockrell HM, Zuckerman M, Wakelin D, Roitt IM, Mims C et al. Mims‟ Medical

Microbiology, Mosby, Fourth edition, 2008, China

73. Gonzalez BE, Martinez-Aguilar G, Hulten KG, Hammerman WA, Coss-Bu J, Avalos-Mishaan A et al. Severe staphylococcal sepsis in adolescents in the era of community-acquired methicillin- resistant Staphylococcus aureus. Pediatrics 2005; 115(3): 642-8.

74. Gonzalez BE, Rueda AM, Shelburne SA et al. Community-associated strains of methicillin- resistant Staphylococccus aureus as the cause of healthcare-associated infection. Infect Control Hosp Epidemiol 2006; 27(10): 1051-6.

75. Greene C, McDevitt D, Francois P, Vaudaux PE, Lew DP, Foster TJ. Adhesion properties of mutants of Staphylococcus aureus defective in fibronectin- binding proteins and studies on the expression of fnb genes. Molecular Microbiology 1995; 17(6):1143-1152.

76. Gülay Z. Antimikrobiyal ilaçlara direnç. In: Ustaçelebi ġ (editör). Temel ve Klinik Mikrobiyoloji. 1. baskı. Ankara: GüneĢ Kitabevi 1999:49, 91-108.

77. Günalp A, Yılmaz YA ve Pınar A. Tıbbi Mikrobiyoloji Laboratuar Egitim Kitabı, Hacettepe Üniversitesi Yayınları, Hacettepe Üniversitesi Hastaneleri Basımevi, Ankara, 2003, 64-67 s, 63-572 p

78. Günaydın M, Esen ġ, Saniç A ve Leblebicioğlu, H. (editörler). SterilizasyonDezenfeksiyon ve Hastane Ġnfeksiyonları. Simad Yayınları, 2002, Samsun.

79. Harbarth S, Françoıs P, Schrenzel J, Fankhauser-Rodrıguez C, Hugonnet S, Koessler T, Huyghe A, Pıttet, D. Community Associated Methicillin Resistant Staphylococcus aureus. Switzerland. Emerging Infectious Diseases,2005, 11: 962-965.

80. Hasbek M, Hakgüdener Y, Kaya S, Bakıcı MZ. Stafilokoklarda Metisilin Direncinin Farklı Yöntemlerle Belirlenmesi ve Çoğul Antibiyotik Direnci. CÜ Tıp Fakültesi Dergisi, 2002, 24 (4): 179–184,

81. Hawkey PM. The growing burden of antimicrobial resistance. J Antimicrob Chemother 2008; 62 (Suppl 1):i1-9.

82. Haznedaroglu T. http://www.gata.edu.tr/infkom/MRSA.pdf (13.02.2013) Metisilin dirençli S. aureus (MRSA) (korunma ve kontrol), Egitim Kitapçıgı, 2008, 1-9 s.

83. Hidron AI, Kourbatova EV, Halvosa JS, Terrel BJ. Risk factors for colonization with Methicillin- Resistant Staphylococcus aureus (MRSA) inpatients admitted to an urban hospital: Emergence of community-associated MRSA nasal carriage. Clin Infect Dis 2005; 41:159-66

84. Hisata K, Kuwahara-Araı K, Yamanoto M, Ito T, Nakatomı Y, Cuı L et al. Dissemination of Methicillin-Resistant Staphylococci among Healthy Japanese Children. Journal of Clinical Microbiology, 2005, 43: 3364-3372.

85. Holden MT, Feil EJ, Lindsay JA. Complet genomes of two clinical S. aureus strains: evidence for the rapid evolution of virulance and drug resistance. Proceeding of the national academy of scences of USA, 2004; 101:9786-9791.

86. Holt JG, Krieg NR, Sneath PHA, Staley JT, Williams ST. Bergey‟s manual of determinative bacreriology. In: Hensly W (Eds). Characteristics differentiating thespecies and subspecies of the genus Staphylococcus. 9th ed. Baltimore: Williams&Wilkins; 1994. p.544-51.

87. Hussain Z, Stoakes L, Garrow S, Longo S, Fitzgerald V, Lannigan R. Rapid detection of mecA- positive and mecA-negative coagulase-negative staphylococci by an anti-penicillin binding protein 2a slide latex agglutination test. J Clin Microbiol. 2000;38(6):2051-4.

88. International Working Group on the Classification of Staphylococcal Cassette Chromosome Elements (IWGSCC). Classification of staphylococcal cassette chromosome mec (SCCmec): guidelines for reporting novel SCCmec elements. Antimicrob Agents Chemother 2009; 53(12): 4961-7.

89. International Working Group on the Classification of Staphylococcal Cassette Chromosome (SCC) Elements (IWG-SCC). http://www.sccmec.org. Son EriĢim: 2013

90. Ito T, Katayama Y, Asada K., Mori N., Tsutsumimoto K., Tiensasitorn C et al. Structural comparison of three types of staphylococcal cassette chromosome mecintegrated in the

66

chromosome in methicillin-resistantStaphylococcus aureus. Antimicrob Agents Chemother 45:1323-36.

91. Joklik WK, Willett HP, Amos DB, Wilfert CM. Staphlococcus. In: Joklik WK, Willett HP, Amos DB, Wilfert CM (eds). Zinsser Microbiology. Twentieth edition, Appleton and Lange, Newyork 1992, pp 401 –416.

92. Jonsson K, Signal C, Muller HP, Lindberg M. Two different genes encode fibronectin binding protein in Staphylococcus aureus. The complete nucleotide sequence and chracterization of the second gene. European Journal Biochemistry 1991;202(3): 1041-1048.

93. Johansson A, Flock JI, Svensson O. Collagen and fibronectin binding in experimental staphylococcal osteomyelitis. Clinical Orthopaedics 2001;382:241-246.

94. Kampf G, Adena S, Ruden H, Weist K. Inducibility and potential role of mecA gene-positive oxacillin-susceptible Staphylococcus aureus from colonized healthcare workers as a source for nosocomial infections. J Hosp Infect 2003; 54:124–9.

95. Karabiber N. Normal populasyonda ve hastane laboratuvar personelinde Staphylococcus aureus burun

taĢıyıcılığı. Mikrobiyol Bul 1991, 25: 187-191.

96. Karahan ZC, Tekeli A, Adaleti R, Koyuncu E, Dolapcı I, Akan OA et al. Investigation of Panton- Valentine leukocidin genes and SCCmec typesin clinical Staphylococcus aureus isolates from Turkey. Microb Drug Resist 2008; 14(3): 203-10.

97. Katayama Y, Ito T, Hiramatsu K. A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 2000; 44(6): 1549-55.

98. Kawamura Y, Hou XD, Sultana F. Distribution of Staphylococcus species among human clinical specimens and emenged description of Staphylococcus caprae. Journal of Clinical Microbiology, 1998;36: 2038- 2042.

99. Kayser FH, Eckert J, Bienz KA, Zinkernagel RM. Tıbbi Mikrobiyoloji, Anlamak, Ögrenmek, Basvurmak için. Nobel Tıp Kitabevleri, 9. baskı, Ġstanbul, 2002, 153-226 p.

100. Kılıç A, Güçlü AU, Senses Z, Bedir O, Aydoğan H, BaĢustaoğlu AC. Staphylococcal cassette chromosome mec (SCCmec) characterization and panton-valentine leukocidin gene occurrence for methicillin-resistant Staphylococcus aureus in Turkey, from 2003 to 2006. Antonie Van Leeuwenhoek 2008; 94(4): 607-14.

101. Kloos WE, Lambe DW. Staphylococcus. In: Balows A, Hausler WJ, Hermann K, Isenberg HD, Shadamy HJ (eds). Manual of Clinical Microbiology 5 th edition. American Society for Microbiology, Washington DC, 1991; 222 –238.

102. Kloos WE, Bannerman TL. Staphylococcus and Micrococcus. In: Murray PR, Baran EJ, Pfaller MA, Tenover FC, Yolker RH (eds). Manual of Clinical Microbiology. 6th ed. Washington, DC: ASM Pres, 1995: 282-98

103. Kluytmans JA, Mouton JW, Ijzerman EP. Nasal carriage of Staphylococcus aureus as a major risc factor for wound infections after cardiac surgery. J Infect Dis. 1995; 171:216-219

104. Kluytmans J, Van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms and associated risks. Clinical Microbiology Reviews 1997; 10: 505-20.

105. Kluytmans JA, Wertheim HF. Nasal Carriage of Staphylococcus aureus and Prevention of Nosocomial Infections. Infection, 2005, 33: 3-8.

106. Kluytmans-Vandenbergh MF, Kluytmans JA. Community-acquired methicillin-resistant Staphylococcus aureus: current perspectives. Clinical Microbiology Infection 2006;12: 9-15.. 107. Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn WC. Gram-positive cocci:

Part–1: Staphylococci and related organisms. Color Atlas and text book of diagnostic microbiology, 5th ed. Philadelphia: JB Lippincott Co; 1997 p. 550-649.

108. Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn WC. The Gram Positive Cocci. The Color Atlas and Text Book of Diagnostic Microbiology.6th ed. Philadelphia: JB Lippincott Co.2006:623-671.

109. Kuyucu N. Antibiyotik direnci. Çocuk Enf Derg 2007;1 (Özel sayı 1):33-8.

110. Kutlu S. S. aureus suĢlarında metisilin direnci ve e-test ile vankomisin MIC değerlerinin araĢtırılması (uzmanlık tezi). Ġstanbul: Sağlık Bakanlığı Haseki Eğitim veAraĢtırma Hastanesi; 2006.

111. Kwon NH, Park KT, Moon JS, Jung WK, Kim SH, Kim JM et al. Staphylococcal cassette choromosome mec (SCCmec) characterization and molecular analysis for methicillin- resistant Staphylococcus aureus and novel SCCmec subtype IVg isolated from bovine milk in Korea. Journal Antimicrobial Chemotheraphy 2006; 56: 624-632.

67

112. Lachica RVF, Genigeorgis C, Hoeprich PD. Metachromatic agar-diffusion methods fordetecting stafilococcal nuclease activity. Applied Microbiology 1971, 21(4):585-587.

113. Lammers A, Nuijten PJM, Smith HE. The fibronectin binding proteins of Staphylococcus aureus are required for adhesion to and invasion of bovine mammary glandcells. FEMS Microbiology Letters 1999;180:103-109

114. Layton MC, Hierholzer WJ, Patterson JE. The evolving epidemiology of methicillin resistant Staphylococcus aureus at a university hospital. Infect Control Hosp Epidemiol. 1995, 16:12- 17.

115. Leclercq R, Courvalin P. Intrinsic and unusual resistance to macrolide, lincosamide and streptogramin antibiotics in bacteria. Antimicrob Agents Chemother. 1991;35: 1273-1276 116. Lee YL, Cesario T, Pax A, Tran C, Ghouri S, Thrupp LD. Nasal colonization by Staphylococcus

aureus in active, independent, community seniors, short report. Age and Ageing 1999;28: 229- 232

117. Lina G, Piemont Y, Godail-Gamot F, Bes M, Peter MO, Gauduchon V et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999; 29(5): 1128-32.

118. Lowy FD. Staphylococcus aureus infections. New England Journal of Medicine, 1998; 339: 520- 532.

119. Lu PL, Chin LC, Peng CF, Chiang YH, Chen TP, Ma L et al. Risk factors and molecular analysis ofcommunity methiccilin-resistant staphylococcus aureus carriage. Journal OfClinical Microbıology, 2005;132–139.

120. Mackie W, McCartney L: Staphylococcus aureus. In: Collee JG, Duguid JP, Fraser AG, Marmion BP (Eds). Practical Medical Microbiology 13 th Edition” Churchill, Livingstone 1989; 305-311.

121. Madigan MT, Martinco JM, Parker J. Procaryotic diversity the Archaea. Brock Biology of Microorganisms, In: Corey, P.F.(editor) 2000; 321-322.

122. Maiden MC, Brgraves JA, Feil E, Morelli G, Russell JE, Urwin Ret al. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A. 1998; 95: 3140-3145.

123. Maier J, Melzl H, Reischl U, Drubel I, Witte W, Lehn N, Linde, H. Panton-Valentine leukocidin- positive methicillin-resistant- Staphylococcus aureus in Germany associated with travel or foreign family origin. Eur J Clin Microbiol Infect Dis. 2005, 24: 637–39.

124. Maslow JN, Mulligan ME, Arbeit RD. Molecular epidemiology: application of contemporary techniques to typing of microorganisms. Clin Infect Dıs 1993;17: 153–164.

125. McDevitt D, Francois P, Vaudaux P, Foster TJ. Molecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus. Moleculer Microbiology 1994;11: 237- 248.

126. McDougal LK, Steward CD, Killgore GE, Chaitram JM, McAllister SK, Tenover FC. Pulsed- field gel electrophores is typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a nationaldatabase. J Clin Microbiol 2003; 41: 5113-20.

127. McGavin MH, Krajewska-pietrasik D, Ryden C, Höök M. Identification of a Staphylococcusaureus extracellular matrix-binding protein with broad specificity. Infection and Immunology1993;61: 2479-2485.

128. Montesinos I, Salido E, Delgado T, Cuervo M and Sierra A. Epidemiological genotyping of methicillin resistant Staphylococcus aureus by pulsed field gel electrophoresis at a university hospital and comparison with antibiotyping and protein A and coagulase gene polymorphisms. J. Clin. Microbiol. 2002, 40 2119–2125

129. Moreillon P, Entenza JM, Francioli P, McDevitt D, Foster TJ, François P et al. Role of

Staphylococcus aureus coagulase and clumping factor in pathogenesis of

experimentalendocarditis. Infection and Immunology 1995; 63: 4738-4743.

130. Moreillon P, Que Y.A, Glauser M.P. Staphylococcus aureus Including Staphylococcal Toxic Shock, Principles and Practice of Infectious Diseases. In: Mandell G.L. Bennett J.E. Dolin R. (eds). Elsevier Churchill Livingstone, Philadelphia, 2005, s. 2321-2360

131. Moreno F, Crisp C, Jorgensen JH, Patterson JE. Methicillin-Resistant Staphylococcus aureus as a Community Organism. Clinical Infectious Diseases, 1995, 21: 1308-1312.

132. Morgan M. Methicillin- Resistant Staphylococcus aureus in animal: zoonosis or humanosis. Journal of Antimicrobial Chemotheraphy, 2008; 10: 1093-1105.

133. Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken, RH. Manual of Clinical Microbiology, American Society for Microbiology, Seventh edition, Washington, 1999, 264282 p.

68

134. Murray PR, Boron EJ, Pfaller MA, Yolken RH. Gram Positive Cocci: Staphylococcus, Micrococcus and Other Catalase Positive Cocci That Grow Aerobically. Manuel of Clinical Microbiology. ASM Pres, Washington DC. 2003, s. 384-404.

135. Muray PR, Rosenthal KS, Pfaller PA. Medical Microbiology; 4th. Philadelphia: Elsevier. 2005: 203-12;221-36.

136. Murray CK, Holmes RL, Ellis MW, Mende K, Wolf SE, McDaugal LK et al. Twenty-five year epidemiology of invasive methicillin-resistant Staphylococcus aureus (MRSA) isolates recovered at a burn center. Burns 2009; 35: 1112-7.

137. Ni Eidhin D, Perkins S, Francois P, Vaudaux P, Hook M, Foster TJ. Moleculer Microbiology 1998;30: 245-257.

138. Nunes ELC, Santos KGN, Mondino PJJ, Bastos MCF, deMarval MG. Detection of ile S-2 Gene Encoding Mupirosin Resistance in Meticillin-Resistant Staphylococcus aureus by Multiplex PCR. Diag Microbiol Infect 1999;34:77-81.

139. Nyugen MH, Kauffman CA, Goodman RP. Nasal carriage of and infection with Staphylococcus aureus in HIV –infected patients. Ann Intern Med 1999;130:221-225

140. O‟Brien LM, Walsh EJ, Massey, RC, Peacock SJ, Foster TJ. Staphylococcus aureus clumpingfactor B (ClfB) promotes adherence to human type 1 cytokeratin 10: implications for nasalcolonization. Celluler Microbiology 2002;4:759-770.

141. O'Brien FG, Lim TT, Chong FN, Coombs GW, Enright MC, Robinson DA et al. Diversity among community isolates of methicillin-resistant Staphylococcusaureus in Australia. J Clin Microbiol 2004; 42: 3185-90.

142. Okuma K, Iwakawa K, Turnidge JD, Grubb WB, Bell JM, O‟Brien FG, et al. Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J Clin Microbiol 2002; 40(11): 4289-94.

143. Oldberg A, Franzen A, Heinegard D. The primary structure of a cell-binding bone sialoprotein. Journal of Biologigal Chemistry 1988;263: 19430-19432.

144. Oliveira, DC, Tomasz A, de Lencastre H. The evolution of pandemic clones of methicillin resistant Staphylococcus aureus: identification of two ancestral genetic backgrounds and the associated mec elements. Microb. Drug Resist. 2001; 349-361.

145. Oliveira DC, Lencastre H. Multiplex PCR Strategy for Rapid Identification of Structural Types and Variants of the mec Element in Meticillin-Resistant Staphylococcus aureus. Antimicrob Agents Chemother 2002;46:2155-61

146. Öncül A. Toplumda ve hastanede edinilmiĢ nazal stafilokok taĢıyıcılığında risk faktörleri ve direnç durumlarının karĢılaĢtırılması (tez). Ġstanbul: Sağlık Bakanlığı ġiĢli Etfal Eğitim ve AraĢtırma Hastanesi ;2006.

147. Öztop AY, Pinarbasi H, Kocagöz S, Bakici MZ, Bakir M. Molecular genotyping of methicillin- resistant Staphylococcus aureus strains in a teaching hospital in Turkey.Microb Drug Resist. 2004; 10(2):154-9.

148. Palmqvist N, Foster T, Tarkowski A, Josefsson E. Protein A is an virulence factor in Staphylococcus aureus arthritis and septic death. Microbial Pathogenesis 2002; 33:239-249. 149. Palmqvist N, Foster T, Fitzgerald JR, Josefsson E, Tarkowski A. Fibronectin binding proteinsand

fibrinogen-binding clumping factors play distinct roles in staphylococcal arthritis and systemic inflammation. Journal Infection Disease 2005;191:791-798.

150. Park PW, Rosenbloom J, Abrams WR, Rosenbloom J, Mecham RP. Molecular cloning and expression of the gene for elastin-binding protein (ebpS) in Staphylococcus aureus. Journal of Biological Chemistry 1996;271:15803-15809.

151. Patel M, Hoesley CJ, Moser SA, Stamm A, Baddley JW, Waıtes KB. Dissemination of Community-Associated Methicillin-Resistant Staphylococcus aureus in a Tertiary Care Hospital. Southern Medical Journa l, 2008, 101: 40-45.

152. Patti JM, Bremell T, Krajewska-Pietrasik D, Abdelnour A, Tarkowski A, Rydén C et al. The Staphylococcus aureus collagen adhesin is a virulence determinant in experimental septicarthritis. Infection and Immunology 1994;62:152-161.

153. Peacock SJ. Staphylococcus. In Borriello SP. Murray PR, Funke G (eds). Topley & Wilson‟s Microbiology and Microbial Infections. 10. Baskı. Hodder Arnold, London, United Kingdom, 2005; 771-832.

154. Pfaller MA. Chromosal restriction fragment analysis by pulsed -field gel electrophoresis ampplication to molecular epidemiology. In: section 10: molecular biology. In: Isenberg HD (eds). Essential prosedures for clinical microbiology, ASM Pres, Washington 1998, pp 651- 657.

69

155. Polat, Y. Eskisehir Hastanelerinde Saglık Çalısanlarındaki Nazal Staphylococcus aureus ve MRSA Tasıyıcılıgı, Doktora Tezi, Osmangazi Üniversitesi Sağlık Bilimleri Enstitüsü, 1998, 20-34 s.

156. Poyraz O, Oztop Y, Tekait H. Hastane personeli ve genel toplumdaStaphylococcus aureus burun tasıyıcılığı oranı ve çesitli antibakteriyellere direnc. C.U.Tıp Fakultesi Derg. 1999;21.253-260 157. Projan SJ, Novick RP. The Staphylococci in Human Disease pathogenicity. In: Crossley KB,

Archer GL (Eds). The molecular basis of Churchill. New York: Livingstone Inc; 1997. p.55- 81.

158. Qadri SM, Ueno Y, Imambaccus H, Almodovar E. Rapid detection of methicillin resistant Staphylococcus aureus by Crystal MRSA ID System. J Clin Microbiol. 1994;32(7):1830-2. 159. Rehm SJ, Tice A. Staphylococcus aureus: methicillin-susceptible S. aureus to methicillin-

resistant S. aureus and vancomycin-resistant S. aureus. Clin Infect Dis 2010; 51(Suppl 2): S176-82.

160. Said-Salim, B, Mathema, B, Kreiswirth, BN. Community-acquired methicillin-resistant Staphylococcus aureus: an emerging pathogen. Infect Control Hosp Epidemiol 24, 2003, 451– 455s.

161. Sakuolas G, Gold HS, Venkataraman L, Degirolami PC, Eliopoulos GM, Oıan Q. Meticillin- Resistant Staphylococcus aureus: Comparison of Susceptibility Testing Methods and Analysis of mecA Positive Susceptible Strains. J Clin Microbiol 2001;39:3946-51.

162. Salgado CD, Farr BM, Calfee DP. Community-acquired methicillin resistant Staphylococcus aureus: a metaanalysis of prevalence and risk factors. Clin Infect Dis 2003; 36: 131-9.

163. Sancak, B. Staphylococcus aureus’ ta metisilin ve vankomisin direnci, Hacettepe Tıp Dergisi, 2007,38, 3, 127-134 s

164. Sancak B. Staphylococcus aureus ve antibiyotik direnci, Mikrobiyol Bul 2011;45(3):565-76. PMid:21935792

165. Saulnier P, Bourneix C, Prevost G, Andremont A. Random amplified polymorphic DNA assay is less discriminant than pulsed-field gel electrophoresis for typing strains of methicillin - resisatant Staphlococcus aureus. J Clin Microbiol 1993; 31: 982–985.

166. Schaffer AC, Solinga RM, Cocchiaro J, Portoles M, Kiser KB, Risley A et al. Immunization with Staphylococcusaureus clumping factor B, a major determinant in nasal carriage, reduces nasal colonization ina murine model. Infection and Immunology 2006;74:2145-2153.

167. Shimaoka M, Yoh M, Segawa A, Takarada Y, Yamamoto K, Honda T. Development of enzyme- labeled oligonucleotide probe for detection of mecA gene in methicillin-resistant Staphylococcus aureus. J Clin Microbiol. 1994;32(8):1866-9.

168. Shopsin B, Mathema B, Martinez J. Prevalance of Methicillin-Resistant and Methicillin- Susceptible Staphyococcus aureus in the Community. JID 2000; (July): 359-362

169. Shorr AF. Epidemiology of staphylococcal resistance. Clin Infect Dis 2007; 45(Suppl 3): S171- 170. Sieradazki K, Roberts RB, Haber SW, Tomasz, A. The development of vankomycin resistance

in a patient with methicillin-resistant Staphylococcus aureus infection, N Engl J Med, 1999, 340, 7, 517-523 p

171. Spink WW and Ferris V. Quantitative action of penicillin inhibitor from penicilin resistant strains of staphylococci. Science 1945, 102:221.

172. Switalski L, Patti JM, Butcher, W, Gristina AG, Speziale P, Höök M. A collagen receptor of Staphylococcus aureus strains isolated from patients with septic arthritis mediates adhesion to cartilage. Moleculer Microbiology 1993;7:99-107.

173. Tambic A, Power EGM, Talsania H. Analysis of outbreak of nonphage-typeable methicillin- resistant Staphylococcus aureus by using a randomylamplified polymorphic DNA assay. J. Clin. Microbiol. 1997, 35 : 3092-3097.

174. Taponen S, Pyorala S. Coagulase-negative Staphylococci as cause of bovine mastitis not sodifferent from Staphylococcus aureus? Veterinary Microbiology, 2009; 134:29-36.

175. Temiz, A. Genel Mikrobiyoloji Uygulama Teknikleri, Hatipoglu Yayınevi, Sahin Matbaası, 2. baskı, Ankara, 1996,118-125 s.

176. Thornsberry C, McDougal LK. Successful use of broth microdilution insusceptibility tests for methicillin-resistant (heteroresistant) staphylococci. J Clin Microbiol.1983;18(5):1084-91. 177. Timbury MC, McCartney A, Thakker B. Notes on Medical Microbiology. Churchill Livingstone,

Elsevier Limited, 2002; 31-34 New York, USA.

178. Todar K. Staphylococcus. Todar‟s Online Textbook of Bacteriology.EriĢim Adresi; http://textbookofbacteriology.net/staph.html. Son EriĢim Tarihi: 11.02.2013

179. Topçu AW, Söyletir G, Doğanay M (eds). Ġnfeksiyon hastalıkları ve mikrobiyolojisi, etkenlere göre infeksiyonlar, Nobel Tıp Kitabevleri, Nobel Matbaacılık, Ġstanbul, 2, 2002, 1507-1514 s.

70

180. Tung HS, Guss B, Hellman U, Persson L, Rubin K, Ryden C. A bone sialoprotein-binding protein from Staphylococcus aureus: a member of the staphylococcal Sdr family. Biochemical Journal 2000;345:611-619.

181. Turner K, Uttley L, Scrimgeour A. Natural history of Staphylococcus aureusnasal carriage and its relationship to exit-site infection. Perit Dial Int.1998;18:271-273

182. Tünger A, Çavusoglu C ve Korkmaz M. Asya Mikrobiyoloji, Asya Tıp Yayıncılık, 3. baskı, Ġzmir, 2003, 41-50 s.

183. Tünger A. Staphylococcus aureus mikrobiyoloji, patogenez ve epidemiyoloji. In: Ulusoy S,Usluer G, Ünal S (Eds) . Önemli ve sorunlu Gram pozitif bakteri infeksiyonları. Ankara: Bilimsel Tıp Yayınevi, 2004; 9-22.

184. Tünger A, ÇavuĢoğlu C, Korkmaz M. Asya Mikrobiyoloji. Ġzmir, Türkiye: Asya Tıp Kitapevi; 2005. p. 71-85.

185. Turlej A, Hryniewicz W, Empel J. Staphylococcal cassette chromosome mec (Sccmec) classification and typing methods: an overview, Pol J Microbiol 2011;60(2):95-103. PMid:21905625

186. Ubukata K, Nakagami S, Nitta A, Yamane A, Kawakami S, Sugiura M et al. Rapid detection of the mecA gene in methicillin-resistant staphylococci by enzymatic detection of polymerase chain reaction products. J Clin Microbiol. 1992;30(7):1728-33.

187. Ulusoy S, Usluer G, Ünal S (Eds). Önemli ve Sorunlu Gram-Pozitif Bakteri Ġnfeksiyonları, Bilimsel Tıp Yayınevi, Ankara, 2004, 9-71 s.

188. Unal S. Akhan S. Stafilokok Enfeksiyonları. In: Topcu AW, Soyletir G. Doğanay M (eds). Enfeksiyon Hastalıkları Kitabı. Birinci baskı, Nobel Tıp Kitabevleri Ġstanbul.1996; 773–781. 189. Verhoef J, Fluit AC, Schmitz FJ: Staphylococci and other Micrococcaceae. Infectious Diseases.

In: Cohen J., Powderly WG. Elsevier Limited (eds). Philadelphia, 2004, s.2119-2132.

190. Valsesia G, Rossi M, Bertschy S, Pfyffer GE. Emergence of SCCmec type IV and SCCmec type V methicillin resistant Staphylococcus aureus containing the Panton-Valentine leukocidin genes in a large academic teachinghospital in central Switzerland: external invaders or persisting circulators? J Clin Microbiol 2010; 48:720-7.

191. Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, Heffernan H et al. Community- acquired methicillin-resistant Staphylococcus aureuscarrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 2003; 9: 978-84.

192. Vaudaux P, Pittet D, Haeberli A, Lerch PG, Morgenthaler JJ, Proctor RA et al. Fibronectin is more active than fibrin or fibrinojen in promoting Staphylococcus aureus adherence to inserted intravascular catheter. Journal Infectious Diseases 1993, 167:633-641.

193. Verhoef J, Schmitz FJ. Staphylococci and the micrococaceae.”Armstrong D, Cohen J (ed) : Infectious Diseases”, p 8.13.1, Mosby-Harcourt Publishers Ltd , London, 1999.